Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a

肾切除术 医学 肾细胞癌 阶段(地层学) 病态的 外科 比例危险模型 泌尿科 内科学 古生物学 生物
作者
Paras Shah,Daniel M. Moreira,Vinay Patel,Geoffrey S. Gaunay,Arvin K. George,Manaf Alom,Zachary Kozel,Oksana Yaskiv,Simon J. Hall,Michael J. Schwartz,Manish Vira,Lee Richstone,Louis R. Kavoussi
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:198 (2): 289-296 被引量:68
标识
DOI:10.1016/j.juro.2017.03.012
摘要

We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage T3a.We retrospectively reviewed the records of 1,250 patients who underwent partial or radical nephrectomy for clinically localized T1 renal cell carcinoma between 2006 and 2014. Recurrence-free survival was estimated using the Kaplan-Meier method and evaluated as a function of nephrectomy type with the log rank test and Cox models, adjusting for clinical, radiological and pathological characteristics.A total of 86 recurrences (7%) were observed during a median followup of 37 months. No difference in recurrence-free survival between partial and radical nephrectomy was found among all clinical stage T1 renal cell carcinomas. T3a up staging was noted in 140 patients (11%) and recurrent disease was observed in 44 (31.4%) during a median followup of 38 months. Among up staged T3a cases partial nephrectomy was associated with shorter recurrence-free survival compared to radical nephrectomy on univariable analysis (recurrence HR 2.04, 95% CI 1.12-3.68, p = 0.019) and multivariable analysis (recurrence HR 5.39, 95% CI 1.94-14.9, p = 0.001).In a subgroup of patients clinically staged T1 renal cell carcinoma will be pathologically up staged to T3a. Among these patients those who undergo partial nephrectomy appear to have inferior recurrence-free survival relative to those who undergo radical nephrectomy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YangMengting完成签到 ,获得积分10
2秒前
诺奇发布了新的文献求助30
2秒前
wyhhh完成签到,获得积分10
3秒前
欣欣子完成签到 ,获得积分10
5秒前
谨慎的凝丝完成签到,获得积分10
7秒前
小晚完成签到,获得积分10
8秒前
乾乾完成签到,获得积分10
8秒前
xxxx发布了新的文献求助10
9秒前
陈龙完成签到,获得积分10
12秒前
xue112完成签到 ,获得积分10
13秒前
czt完成签到 ,获得积分10
14秒前
喜悦彩虹完成签到,获得积分10
15秒前
那时年少完成签到,获得积分10
16秒前
浅浅殇完成签到,获得积分10
16秒前
chiazy完成签到,获得积分10
18秒前
娅娃儿完成签到 ,获得积分10
19秒前
gcl应助科研通管家采纳,获得30
19秒前
19秒前
从来都不会放弃zr完成签到,获得积分10
19秒前
bb完成签到,获得积分10
23秒前
冷酷仙境的羊男应助诺奇采纳,获得10
23秒前
冰姗完成签到,获得积分10
23秒前
科研王子完成签到,获得积分10
23秒前
量子星尘发布了新的文献求助10
24秒前
fuws完成签到 ,获得积分10
25秒前
笨笨棒球应助佰斯特威采纳,获得50
27秒前
苏素完成签到,获得积分10
27秒前
韭菜盒子发布了新的文献求助10
27秒前
岑夜南完成签到,获得积分10
31秒前
披着羊皮的狼完成签到 ,获得积分10
31秒前
超帅的凌翠完成签到,获得积分10
31秒前
水星完成签到 ,获得积分0
31秒前
halo完成签到,获得积分10
33秒前
XIAO完成签到 ,获得积分10
33秒前
35秒前
plant完成签到,获得积分10
37秒前
小小智完成签到,获得积分0
37秒前
聪慧的石头完成签到,获得积分10
37秒前
可玩性完成签到 ,获得积分10
38秒前
jkjkjk完成签到,获得积分10
38秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3953529
求助须知:如何正确求助?哪些是违规求助? 3498988
关于积分的说明 11093633
捐赠科研通 3229626
什么是DOI,文献DOI怎么找? 1785674
邀请新用户注册赠送积分活动 869464
科研通“疑难数据库(出版商)”最低求助积分说明 801470